# A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)

> **NCT06350565** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 48 (estimated)

## Conditions studied

- Respiratory Distress Syndrome of Newborn

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT06350565
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-30
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06350565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06350565, "A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06350565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*